Diagnosis, classification, and treatment of retinoblastoma

International Ophthalmology Clinics

Volumn 48, Issue 2, 2008, Pages 135-147

  Kiss, Szilárd ^a   Leiderman, Yannek I ^a   Mukai, Shizuo ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOSPORIN; ETOPOSIDE; VINCRISTINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CATARACT; CHILDHOOD CANCER; CHONDROSARCOMA; CLINICAL FEATURE; CORNEA DISEASE; CRYOTHERAPY; DISEASE CLASSIFICATION; ENUCLEATION; EXUDATIVE RETINITIS; EYE PAIN; GLAUCOMA; GLIOMA; HUMAN; INCONTINENTIA PIGMENTI; INTRACRANIAL TUMOR; LASER COAGULATION; LEUKEMIA; LEUKOKORIA; MELANOMA; METASTASIS; NEUROBLASTOMA; NORRIE DISEASE; ORBIT CELLULITIS; ORBIT INFLAMMATION; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; RETINOBLASTOMA; RETINOPATHY; RETROLENTAL FIBROPLASIA; REVIEW; RHABDOMYOSARCOMA; SEBACEOUS CARCINOMA; SPINDLE CELL SARCOMA; SQUAMOUS CELL CARCINOMA; STRABISMUS; TOXOCARIASIS; VISUAL ACUITY; VISUAL DISORDER; VITREOUS HEMORRHAGE;

CHILD, PRESCHOOL; HUMANS; INFANT; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 42449127634     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181693670     Document Type: Review

References (51)

1. Mahoney MC, Burnett WS, Majerovics A, et al. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology. 1990;97:1143-1147.
2. Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci. 2005;46:2683-2691.
3. Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene. 2006;25:5341-5349.
4. Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17:228-234.
5. Hilgartner H. Report of a case of double glioma treated by x-ray. Texas Med J. 1903;18:322-323.
6. Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004;24:828-848.
7. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68:820-823.
8. Zhang J, Gray J, Wu L, et al. Rb regulates proliferation and rod photoreceptor development in the mouse retina. Nat Genet. 2004;36:351-360.
9. Zheng L, Lee WH. The retinoblastoma gene: a prototypic and multifunctional tumor suppressor. Exp Cell Res. 2001;264:2-18.
10. Seregard S, Lundell G, Svedberg H, et al. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Ophthalmology. 2004;111:1228-1232.
11. Abramson DH. Retinoblastoma incidence in the United States. Arch Ophthalmol. 1990;108:1514.
12. Buckley JD. The aetiology of cancer in the very young. Br J Cancer Suppl. 1992;18:S8-S12.
13. Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res. 2000;6:4010-4016.
14. Orjuela MA, Titievsky L, Liu X, et al. Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma. Cancer Epidemiol Biomarkers Prev. 2005;14:1433-1440.
15. Yip BH, Pawitan Y, Czene K. Parental age and risk of childhood cancers: a population-based cohort study from Sweden. Int J Epidemiol. 2006;35:1495-1503.
16. Dryja TP, Morrow JF, Rapaport JM. Quantification of the paternal allele bias for new germline mutations in the retinoblastoma gene. Hum Genet. 1997;100:446-449.
17. Greger V, Debus N, Lohmann D, et al. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet. 1994;94:491-496.
18. Moll AC, Imhof SM, Kuik DJ, et al. High parental age is associated with sporadic hereditary retinoblastoma: the Dutch retinoblastoma register 1862-1994. Hum Genet. 1996;98:109-112.
19. Kato MV, Ishizaki K, Shimizu T, et al. Parental origin of germ-line and somatic mutations in the retinoblastoma gene. Hum Genet. 1994;94:31-38.
20. Zhu XP, Dunn JM, Phillips RA, et al. Preferential germline mutation of the paternal allele in retinoblastoma. Nature. 1989;340:312-313.
21. Munier F, Spence MA, Pescia G, et al. Paternal selection favoring mutant alleles of the retinoblastoma susceptibility gene. Hum Genet. 1992;89:508-512.
22. Abramson DH. Second nonocular cancers in retinoblastoma: a unified hypothesis. The Franceschetti Lecture. Ophthalmic Genet. 1999;20:193-204.
23. Walton DS, Mukai S, Grabowski EF, et al. Case records of the Massachusetts General Hospital. Case 5-2006. An 11-year-old girl with loss of vision in the right eye. N Engl J Med. 2006;354:741-748.
24. Moll AC, Imhof SM, Meeteren AY, et al. At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98. Br J Ophthalmol. 2000;84:1170-1172.
25. Shields CL, Shields JA, Shah P. Retinoblastoma in older children. Ophthalmology. 1991;98:395-399.
26. Abramson DH, Frank CM, Susman M, et al. Presenting signs of retinoblastoma. J Pediatr. 1998;132(3 Pt 1):505-508.
27. Shields CL, Gorry T, Shields JA. Outcome of eyes with unilateral sporadic retinoblastoma based on the initial external findings by the family and the pediatrician. J Pediatr Ophthalmol Strabismus. 2004;41:143-149; quiz 72-73.
28. Butros LJ, Abramson DH, Dunkel IJ. Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences. Pediatrics. 2002;109:E45.
29. Palazzi M, Abramson DH, Ellsworth RM. Endophytic vs exophytic unilateral retinoblastoma: is there any real difference? J Pediatr Ophthalmol Strabismus. 1990;27:255-258.
30. Abramson DH, Gombos DS. The topography of bilateral retinoblastoma lesions. Retina. 1996;16:232-239.
31. Bhatnagar R, Vine AK. Diffuse infiltrating retinoblastoma. Ophthalmology. 1991;98:1657-1661.
32. Shields CL, Honavar S, Shields JA, et al. Vitrectomy in eyes with unsuspected retinoblastoma. Ophthalmology. 2000;107:2250-2255.
33. Shields JA, Parsons HM, Shields CL, et al. Lesions simulating retinoblastoma. J Pediatr Ophthalmol Strabismus. 1991;28:338-340.
34. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:164-172.
35. Shields JA, Shields CL, Meadows AT. Chemoreduction in the management of retinoblastoma. Am J Ophthalmol. 2005;140:505-506.
36. Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276-2280.
37. Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am. 2005;18:41-53, viii.
38. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94:371-377.
39. Uusitalo MS, Van Quill KR, Scott IU, et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol. 2001;119:41-48.
40. Shields CL, Meadows AT, Leahey AM, et al. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004;24:849-862.
41. Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol. 1999;17:1829-1837.
42. Shields CL, Meadows AT, Shields JA, et al. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001;119:1269-1272.
43. Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96:357-363.
44. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988;95:1583-1587.
45. Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology. 2001;108:1868-1876.
46. Chan HS, Gallie BL, Munier FL, et al. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am. 2005;18:55-63, viii.
47. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol. 2002;133:657-664.
48. Shields CL, Shields JA, Needle M, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1997;104:2101-2111.
49. Epstein JA, Shields CL, Shields JA. Trends in the management of retinoblastoma: evaluation of 1196 consecutive eyes during 1974 to 2001. J Pediatr Ophthalmol Strabismus. 2003;40:196-203; quiz 17-18.
50. Shields CL, Mashayekhi A, Cater J, et al. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138:329-337.
51. Shields CL, Shelil A, Cater J, et al. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Arch Ophthalmol. 2003;121:1571-1576.